References
- ScanlonPHDiabetic retinopathyMedicine201038656660
- FanteRJDurairajVDOliverSCNDiabetic retinopathy: An update on treatmentAm J Med201012321321620193825
- AlghadyanAADiabetic retinopathy – an updateSaudi J Ophthalmol20112599111
- KimYHChungIYChoiMYTriamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxiaNeurobiol Dis20072656957617434742
- ChungHSHarrisAHalterPJRegional differences in retinal vascular reactivityInvest Ophthalmol Vis Sci1999402448245310476818
- IshidaSUsuiTYamashiroKVEGF164 is proinflammatory in the diabetic retinaInvest Ophthalmol Vis Sci2003442155216212714656
- FunatsuHYamashitaHNomaHRisk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin IIBr J Ophthalmol2004881064106815258026
- OgataNNishikawaMNishimuraTMitsumaYMatsumuraMUnbalance vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathyAm J Ophthalmol200213434835312208245
- SydorovaMLeeMSVascular endothelial growth factor in virtreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathyOphthalmic Res20053718819015990461
- JermakCMDellacroceJTHeffezJPeymanGATriamcinolone acetonide in ocular therapeuticsSurv Ophthalmol20075250352217719372
- JonasJBKreissigIDegenringRIntravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseasesProg Retinal Eye Res200524587611
- OzdekSCAydinBGurelikGBahceciUHasanreisogluBEffects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusionInt Ophthalmol2006162734
- KimYHChoiMYKimYSTriamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakageLife Sci2007811167117317881007
- ZhangXBaoSLaiDRapkinsRWGilliesMCIntravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinasDiabetes2008571026103318174522
- KimSYYangJLeeYCParkYHEffect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgeryJ Cataract Refract Surg20083482382618471640
- OhJJungYSKimMYThe effect of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cellsActa Ophthalmol Scand20078578679017617200
- JoansJBIntravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseasesActa Ophthalmol Scand20058364566316396641
- LiuZJiaoYWangYZhouCZhangZPolysaccharides-based nanoparticles as drug delivery systemsAdv Drug Deliv Rev2008601650166218848591
- YangLKuangJWangJLiZZhangLLoading and in vitro controlled release of indomethacin using amphiphilic cholesteryl-bearing carboxymethylcellulose derivativesMacromol Biosci2008827928618072181
- YangLZhangBWenLLiangQZhangLAmphiphilic cholesteryl grafted sodium alginate derivative: Synthesis and self-assembly in aqueous solutionCarbohydr Polym200768218225
- FuenteMRavinaMPaolicelliPSanchezASeijoBAlonsoMJChitosan-based nanostructures: a delivery platform for ocular therapeuticsAdv Drug Deliv Rev20106210011719958805
- YangLLanYGuoHOphthalmic drug-loaded N,O-carboxymethyl chitosan hydrogels: synthesis, in vitro and in vivo evaluationActa Pharmacol Sin2010311625163421042284
- LiuWHuMLiuWXueCXuHYangXInvestigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetateInt J Pharm200836413514118778760
- LeeKYJoWHKwonICKimYHJeongSYStructural determination and interior polarity of self-aggregates prepared from deoxycholic acid-modified chitosan in waterMacromolecules199831378383
- GottliebHEKotlyarVNudelmanANMR chemical shifts of common laboratory solvents as trace impuritiesJ Org Chem1997627512751511671879
- LiXTZhangYChenGQNanofibrous polyhydroxyalkanoate matrices as cell growth supporting materialsBiomaterials2008293720372818585779
- WuJTechniques and Applications of Modern FTIR SpectroscopyBeijing, ChinaScience Press1994
- KimCLeeSCKangSWKwonICKimYHJeongSYSynthesis and the micellar characteristics of poly(ethylene oxide)-deoxycholic acid conjugatesLangmuir20001647924797
- LuckachanGEPillaiCKSChitosan/oligo L-lactide graft copolymers: effect of hydrophobic side chains on the physico-chemical properties and biodegradabilityCarbohyr Polym200664254266
- PignatelloRBucoloCFerraraPMalteseAPuleoAPuglisiGEudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofenEur J Pharm Sci200216536112113891
- NarayananRMungcalJKKenneyMCSeigelGMKuppermannBDToxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cellsInvest Ophthalmol Vis Sci20064772272816431973
- YeungCKChanKPChiangSWYPangCPLamDSCThe toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinoloneInvest Ophthalmol Vis Sci2003445293530014638729
- NamHYKwonSMChungHCellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticlesJ Control Release200913525926719331853
- ParkJSHanTHLeeKYN-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug releaseJ Control Release2006115374516935380
- TomihataKIkadaYIn vitro and in vivo degradation of films of chitin and its deacetylated derivativesBiomaterials1997185675759105597
- VerheulRJAmidiMSteenbergenMJRietEJiskootWHenninkWEInfluence of the degree of acetylation on the enzymatic degradation and in vitro biological properties of trimethylated chitosansBiomaterials2009303129313519339046
- KwakNOkamotoNWoodJMCampochiaroPAVEGF is major stimulator in model of choroidal neovascularizationInvest Ophthalmol Vis Sci2000413158316410967078
- SengerDRPerruzziCAFederJDvorakHFA highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell linesCancer Res198646562956323756910
- FunatsuHYamashitaHIkedaTMimuraTEguchiSHoriSVitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edemaOphthalmology20031101690169613129863
- KimYSJungDHKimNHKIOM-79 inhibits high glucose or AGEs-induced VEGF expression in human retinal pigment epithelial cellsJ Ethnopharm2007112166172
- MatsudaSGomiFOshimaYTohyamaMTanoYVascular endothelial growth factor reduced and connective tissue growth factor induced by triamcinolone in ARPE19 cells under oxidative stressInvest Ophthalmol Vis Sci2005461062106815728566
- DasSHaddadiAVeniaminSSamuelJDelivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cellsJ Biomed Mater Res200885A983992